Dr. Demirci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190- Is this information wrong?
Summary
- Dr. Hakan Demirci is an ocular oncologist who sees patients at the University of Michigan Kellogg Eye Center in Ann Arbor. His clinical practice focuses on the evaluation and treatment of eye cancers, including intraocular, conjunctival, adnexal, orbital, and periocular cancers in adults and children.
Dr. Demirci serves as the Director of Kellogg’s Ocular Oncology Clinic and his research interests include the translational approach to early diagnosis of eye cancers, targeted treatment of intraocular tumors, and prevention of metastasis. To make an appointment, please call Kellogg’s Ocular Oncology Clinic at 734-763-5874. To refer a patient, please visit www.kellogg.umich.edu/refer.
Education & Training
- Henry Ford HospitalResidency, Ophthalmology, 2007 - 2010
- Graduate HospitalResidency, Internal Medicine, 2001 - 2002
- Hacettepe University FOMClass of 1993
Certifications & Licensure
- MI State Medical License 2004 - 2026
- PA State Medical License 2000 - 2008
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Multispecialty Management of Metastatic Colon Adenocarcinoma Involving the Extraocular Muscles: Primary Excision and Simultaneous Treatment of Strabismus With a Review...Tassapol Singalavanija, Robert Beaulieu, Federica Mingardo, Fereshteh Azad, Steven M Archer, Victor Maurice Elner, Hakan Demirci> ;Ophthalmic Plastic and Reconstructive Surgery. 2024 Mar 21
- Suprachoroidal Space Injection Technique: Expert Panel Guidance.Cunningham, E., Ciulla, T., Wykoff, C., Avery, R., Barakat, M., Boyer, D., Brown, D., Brucker, A., Heier, J., Holekamp, N., Kaiser, P., Khanani, A., Kim, J., Demirci, ...> ;Retina. 2024 Mar 5
- Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.Serbest Ceylanoglu, K., Guneri Beser, B., Singalavanija, T., Juntipwong, S., Worden, F., Demirci, H.> ;Ophthalmic Plastic and Reconstructive Surgery. 2024 Jan 18
- Join now to see all
Journal Articles
- Change in Postoperative Opioid Prescribing Patterns for Oculoplastic and Orbital Procedures Associated with State Opioid LegislationHakan Demirci, Denise S Kim, Christine C Nelson, JAMA Ophthalmology
- Penetration of Carbon Nanotubes into the Retinoblastoma Tumor After Intravitreal Injection in LHBETATAG Transgenic Mice Reti-Noblastoma ModelHakan Demirci, MD, knepublishing.com
Authored Content
- Retinal Whitening After Lung Transplant for Cystic FibrosisJuly 2020
Press Mentions
- Dilemma for Cancer Patients as Life-Saving Meds Are Tied to Vision LossMay 18th, 2018
- Ophthalmologists Link Immunotherapy with a Serious Eye ConditionMay 7th, 2018
Professional Memberships
- Member
Other Languages
- Turkish
Hospital Affiliations
- University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: